Literature DB >> 11354245

TNF alpha is required for hypoxia-mediated right ventricular hypertrophy.

R M Smith1, J McCarthy, M N Sack.   

Abstract

Hypoxia has been shown to activate the pleiotropic cytokine TNFalpha in the lung. TNFalpha in turn, is known to induce pulmonary vasoconstriction. Additional effects of this cytokine in hypoxia mediated cardiopulmonary remodeling are poorly understood. To further evaluate the role of TNFalpha in chronic hypoxia we exposed TNFalpha null (TNFalpha-/-) and wild-type mice to three weeks of hypobaric hypoxia (10% O2). Equivalent erythocytosis (Hematocrit increased by > 40%) developed in both genetic backgrounds. In contrast, right ventricular systolic pressure increased in response to three weeks of hypoxia in the wild-type mice (> or = 75%), yet was unaltered in the TNFalpha-/- mice. Concomitantly right ventricular hypertrophy was attenuated in the TNFalpha-/- mice (35 +/- 5% increase) when compared to wild-type mice (124 +/- 6% increase p < 0.001, n > or = 20). Interestingly in both strains the lung wet weights increased to a similar degree in response to hypoxia. In conclusion, our data demonstrate that TNFalpha is an integral autocoid in chronic hypoxia mediated right ventricular hypertrophy. Moreover, additional components of cardiopulmonary remodeling may be regulated by TNFalpha signaling as suggested by the negligible right ventricular systolic pressure response to hypoxia in the absence of TNFalpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354245     DOI: 10.1023/a:1010811414206

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

Review 1.  Stress pathways and heart failure.

Authors:  K R Chien
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

2.  Tumor necrosis factor blockers in rheumatoid arthritis.

Authors:  D S Pisetsky
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

3.  Anticytokine approaches in pulmonary fibrosis: bringing factors into focus.

Authors:  R K Coker; G J Laurent
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

4.  Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-alpha.

Authors:  C T Taylor; N Fueki; A Agah; R M Hershberg; S P Colgan
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

5.  Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts.

Authors:  T Yokoyama; K Sekiguchi; T Tanaka; K Tomaru; M Arai; T Suzuki; R Nagai
Journal:  Am J Physiol       Date:  1999-06

6.  E-4010, a selective phosphodiesterase 5 inhibitor, attenuates hypoxic pulmonary hypertension in rats.

Authors:  N Hanasato; M Oka; M Muramatsu; M Nishino; H Adachi; Y Fukuchi
Journal:  Am J Physiol       Date:  1999-08

7.  Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction.

Authors:  S F Liu; A Dewar; D E Crawley; P J Barnes; T W Evans
Journal:  J Appl Physiol (1985)       Date:  1992-03

8.  Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression.

Authors:  D L Disch; T A Rader; S Cresci; T C Leone; P M Barger; R Vega; P A Wood; D P Kelly
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

9.  Differential modulation of cytokine production by drugs: implications for therapy in heart failure.

Authors:  A Matsumori; K Ono; Y Sato; T Shioi; Y Nose; S Sasayama
Journal:  J Mol Cell Cardiol       Date:  1996-12       Impact factor: 5.000

10.  Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema.

Authors:  K Kubo; M Hanaoka; T Hayano; T Miyahara; T Hachiya; M Hayasaka; T Koizumi; K Fujimoto; T Kobayashi; T Honda
Journal:  Respir Physiol       Date:  1998-03
View more
  6 in total

1.  Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Authors:  Christine A Petersen; Katherine A Krumholz; Barbara A Burleigh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  PKCε promotes cardiac mitochondrial and metabolic adaptation to chronic hypobaric hypoxia by GSK3β inhibition.

Authors:  Joy McCarthy; Amanda Lochner; Lionel H Opie; Michael N Sack; M Faadiel Essop
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

3.  Age-dependent exacerbation of white matter stroke outcomes: a role for oxidative damage and inflammatory mediators.

Authors:  Shira Rosenzweig; S Thomas Carmichael
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

4.  Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene.

Authors:  Kholiswa C Ngumbela; Michael N Sack; M Faadiel Essop
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

5.  Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.

Authors:  Chi Zhang; Fan Wang; Yingxia Zhang; Yimin Kang; Haisheng Wang; Mingming Si; Liping Su; Xue Xin; Feng Xue; Fei Hao; Lechu Yu; Jinzhong Xu; Yanlong Liu; Mingming Xue
Journal:  J Cell Mol Med       Date:  2015-10-29       Impact factor: 5.310

6.  Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.

Authors:  Grazielle Fernandes Silva; Jaqueline Soares da Silva; Allan Kardec Nogueira de Alencar; Marina de Moraes Carvalho da Silva; Tadeu Lima Montagnoli; Bruna de Souza Rocha; Rosana Helena Coimbra Nogueira de Freitas; Roberto Takashi Sudo; Carlos Alberto Manssour Fraga; Gisele Zapata-Sudo
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.